🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Idiopathic rapid eye movement sleep behavior disorder (iRBD) is characteriz...
Status
Completed
Location
Pitie Salpetriere hospital
Start Date
2014-02
Trial ID
NCT03072940
Treatments Being Tested
Because of a shared ontogenic origin, the retina displays similarities to t...
Status
Unknown
Location
UZ Leuven
Start Date
2018-03-01
Trial ID
NCT03466177
Treatments Being Tested
NeuroPrems is a prospective, monocentric, longitudinal, not relating to a m...
Status
Not Yet Recruiting
Location
Pitié Salpêtrière Hospital
Start Date
2024-09-01
Trial ID
NCT06516016
The aim of the study is to identify morphological and functional biomarkers...
Status
Unknown
Location
Prof. Stanislao Rizzo
Start Date
2021-01-15
Trial ID
NCT05747144
The purpose of this study is to evaluate the incidence and severity of reti...
Status
Unknown
Location
Department of Ophthalmology and Optometry, Medical University Vienna
Start Date
2023-11-23
Trial ID
NCT06280040
Treatments Being Tested
The main goal of this study is to investigate anatomo-functional brain abno...
Status
Recruiting
Location
Hôpital Necker Enfants Malades
Start Date
2024-04-17
Trial ID
NCT06334588
Treatments Being Tested
Long anterior zonules (LAZ) is an anatomical anomaly of the anterior segmen...
Status
Enrolling By Invitation
Location
Fuzhou Eye Hospital
Start Date
2025-01-10
Trial ID
NCT07549711
Treatments Being Tested
In last decades, several advances in the neuro-intensive management have le...
Status
Unknown
Location
Hôpital Neurologique Pierre Wertheimer
Start Date
2020-11-15
Trial ID
NCT04575454
Treatments Being Tested
The objective of this study is to discover biomarkers that demonstrate a co...
Status
Unknown
Location
Maria Cristina Savastano
Start Date
2024-02-01
Trial ID
NCT06306690
Treatments Being Tested
This phase III trial tests how well the addition of dinutuximab to Inductio...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2024-04-19
Trial ID
NCT06172296
Treatments Being Tested